Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Hold |
21,000
| – | – | 0.53% | 57 |
|
|
2025
Q1 | $715K | Buy |
21,000
+2,000
| +11% | +$68.1K | 0.45% | 66 |
|
|
2024
Q4 | $748K | Buy |
19,000
+4,000
| +27% | +$157K | 0.43% | 66 |
|
|
2024
Q3 | $705K | Buy |
15,000
+1,000
| +7% | +$47K | 0.45% | 67 |
|
|
2024
Q2 | $756K | Buy |
14,000
+4,300
| +44% | +$232K | 0.49% | 61 |
|
|
2024
Q1 | $661K | Hold |
9,700
| – | – | 0.46% | 66 |
|
|
2023
Q4 | $607K | Hold |
9,700
| – | – | 0.5% | 63 |
|
|
2023
Q3 | $607K | Buy |
9,700
+1,700
| +21% | +$106K | 0.5% | 63 |
|
|
2023
Q2 | $449K | Hold |
8,000
| – | – | 0.39% | 71 |
|
|
2023
Q1 | $362K | Buy |
+8,000
| New | +$362K | 0.37% | 67 |
|